Ticker brief
UNCY
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
26
authors 14d
15
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-19 → 2026-07-02 · now +0.00 (−1 bearish … +1 bullish)
Who spoke15
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BPharmCatalyst | C | · | 3 | -0.15 |
| @Omnitrader69 | C | -1.20 | 3 | -0.28 |
| @SandmanMarkets | C | -2.28 | 2 | +0.50 |
| @Maximus_Holla | C | -0.48 | 2 | -0.25 |
| @BiopharmIQ | B | · | 2 | -0.25 |
| @aljehani | C | +0.72 | 2 | -0.18 |
| @BioStocks | C | -0.39 | 2 | -0.27 |
| @Caesar_ish | C | +1.70 | 2 | -0.18 |
| @OptionsFlowBoss | C | · | 2 | +0.00 |
| @TradeIdeas | C | +0.75 | 1 | -0.35 |
| @Quantumup1 | C | -1.95 | 1 | -0.60 |
| @mrland_news | C | · | 1 | -0.45 |
| @PrismMarketView | C | · | 1 | -0.40 |
| @OzmosiHealth | C | · | 1 | -0.50 |
| @FiercePharma | B | +1.39 | 1 | -0.50 |
Recent signals26of 26 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @OptionsFlowBoss | +0.00 | UNCY open-interest changes noted with chart, no clear stance. | · | tweet ↗ |
| 2026-07-01 | @OptionsFlowBoss | +0.00 | Says to check open interest tomorrow for UNCY. | · | tweet ↗ |
| 2026-07-01 | @BioStocks | +0.20 | Noble Capital maintains Outperform but lowers PT to 50. | · | tweet ↗ |
| 2026-07-01 | @aljehani | +0.25 | Despite FDA rejection, notes positive analyst ratings, cash runway and short interest. | · | tweet ↗ |
| 2026-06-30 | @BiopharmIQ | -0.50 | FDA issued CRL for resubmitted OLC NDA; stock down about 45%. | · | tweet ↗ |
| 2026-06-30 | @FiercePharma | -0.50 | Unicycive turned away by FDA again over plant shortfalls. | · | tweet ↗ |
| 2026-06-30 | @OzmosiHealth | -0.50 | Unicycive receives FDA Complete Response Letter for resubmitted Oxylanthanum Carbonate NDA. | · | tweet ↗ |
| 2026-06-30 | @PrismMarketView | -0.40 | Premarket gainers and decliners with percentage moves. | · | tweet ↗ |
| 2026-06-30 | @mrland_news | -0.45 | Top premarket losers list with percentage declines. | · | tweet ↗ |
| 2026-06-30 | @BPharmCatalyst | -0.45 | FDA CRL for resubmitted OLC NDA due to manufacturing issues. | · | tweet ↗ |
| 2026-06-30 | @Caesar_ish | +0.25 | Suggests FDA issue may be manufacturing facility related, leaving approval/recovery possible. | · | tweet ↗ |
| 2026-06-30 | @Caesar_ish | -0.60 | UNCY kidney drug appears FDA rejected, stock down 50% premarket. | · | tweet ↗ |
| 2026-06-30 | @Omnitrader69 | -0.65 | Discloses more ABVX shares and notes UNCY second CRL cut in half again. | · | tweet ↗ |
| 2026-06-30 | @BioStocks | -0.75 | Calls the linked UNCY item horrible. | · | tweet ↗ |
| 2026-06-30 | @Quantumup1 | -0.60 | Says he avoided building a large UNCY position and dodged a bullet. | · | tweet ↗ |
| 2026-06-30 | @aljehani | -0.60 | UNCY received FDA complete response letter and stock was halted/down 36.8%. | · | tweet ↗ |
| 2026-06-30 | @Omnitrader69 | -0.55 | Reports UNCY received second CRL and questions FDA/vendor inspection issue. | · | tweet ↗ |
| 2026-06-30 | @Maximus_Holla | -0.50 | UNCY halted on CRL, an adverse FDA-related event. | · | tweet ↗ |
| 2026-06-29 | @BiopharmIQ | +0.00 | Lists pending June FDA decisions for ARQT and UNCY. | · | tweet ↗ |
| 2026-06-29 | @Omnitrader69 | +0.35 | Author says they have held UNCY for a while and are still holding into PDUFA day. | · | tweet ↗ |
| 2026-06-29 | @Maximus_Holla | +0.00 | Author says no position in UNCY anymore ahead of PDUFA day. | · | tweet ↗ |
| 2026-06-26 | @TradeIdeas | -0.35 | Reports UNCY huge drop, a negative price-performance observation. | · | tweet ↗ |
| 2026-06-22 | @SandmanMarkets | +0.75 | First entry open; add at 7.31 and 6.66; stop below 6.05 — Forward UNCY entry plan with add levels and stop after resistance breakout. | · | tweet ↗ |
| 2026-06-22 | @SandmanMarkets | +0.25 | Scanner watchlist for tomorrow, setups referenced in thread. | · | tweet ↗ |
| 2026-06-19 | @BPharmCatalyst | +0.00 | Biotech watchlist calendar names tickers but gives no stance. | · | tweet ↗ |
| 2026-06-19 | @BPharmCatalyst | +0.00 | Weekly biotech watchlist lists tickers without specific stance. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.